These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 15903286)
21. Hepatic drug metabolism and ageing. Woodhouse KW; James OF Br Med Bull; 1990 Jan; 46(1):22-35. PubMed ID: 2405943 [TBL] [Abstract][Full Text] [Related]
22. The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs. Trenaman SC; Bowles SK; Andrew MK; Goralski K Pharmacol Res Perspect; 2021 May; 9(3):e00775. PubMed ID: 34003603 [TBL] [Abstract][Full Text] [Related]
23. Age-Related Changes in Hepatic Function: An Update on Implications for Drug Therapy. Tan JL; Eastment JG; Poudel A; Hubbard RE Drugs Aging; 2015 Dec; 32(12):999-1008. PubMed ID: 26547855 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics in the elderly. Crooks J; O'Malley K; Stevenson IH Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500 [TBL] [Abstract][Full Text] [Related]
25. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Le Couteur DG; McLean AJ Clin Pharmacokinet; 1998 May; 34(5):359-73. PubMed ID: 9592620 [TBL] [Abstract][Full Text] [Related]
26. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973 [TBL] [Abstract][Full Text] [Related]
27. Liver function and phase I drug metabolism in the elderly: a paradox. Schmucker DL Drugs Aging; 2001; 18(11):837-51. PubMed ID: 11772124 [TBL] [Abstract][Full Text] [Related]
28. Physiologic changes in old age: relation to altered drug disposition. Greenblatt DJ; Divoll M; Abernethy DR; Shader RI J Am Geriatr Soc; 1982 Nov; 30(11 Suppl):S6-10. PubMed ID: 7130589 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacokinetics and the aged person]. Fillastre JP; Moulin B; Dhib M Nephrologie; 1990; 11(5):285-7. PubMed ID: 2090961 [TBL] [Abstract][Full Text] [Related]
30. Optimizing pediatric dosing: a developmental pharmacologic approach. Anderson GD; Lynn AM Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420 [TBL] [Abstract][Full Text] [Related]
37. Effect of maturation on drug disposition in pediatric patients. Stewart CF; Hampton EM Clin Pharm; 1987 Jul; 6(7):548-64. PubMed ID: 3319364 [TBL] [Abstract][Full Text] [Related]
38. Principles and clinical application of assessing alterations in renal elimination pathways. Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929 [TBL] [Abstract][Full Text] [Related]
39. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Woodhouse KW; Wynne HA Clin Pharmacokinet; 1988 Nov; 15(5):287-94. PubMed ID: 3203484 [TBL] [Abstract][Full Text] [Related]
40. Alterations in drug disposition in older adults. Reeve E; Wiese MD; Mangoni AA Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):491-508. PubMed ID: 25600059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]